Cure My Disease

Don't miss your cure!

 Log in / Sign up

New biobank aims to uncover Smoking's role in prostate cancer aggressiveness

NCT ID NCT03232411

Completed Knowledge-focused Sponsor: H. Lee Moffitt Cancer Center and Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study created a biobank of saliva, tumor tissue, and questionnaire data from 592 African American men with prostate cancer in Florida. Researchers want to see if smoking is linked to more aggressive prostate cancer. Participants filled out surveys and provided samples by mail. The goal is to gather information for future research, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this biobank could help researchers understand why prostate cancer is more aggressive in some African American men and whether smoking plays a role.
What could go wrong
This is an observational study that collects data and samples, not a treatment trial. It cannot directly lead to a new therapy or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate disorder Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, 33612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.